Plant-derived Lignans Synthesis and Bioactivity
Plant-derived Lignans Synthesis and Bioactivity is a research topic within Molecular Biology. Science Explorer counts 5.8k research works in it since 1951. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the biosynthesis, pharmacological activities, and medicinal applications of lignans, including compounds such as podophyllotoxin, schisandrin, arctigenin, and related derivatives. It covers research on various plant sources, enzymatic pathways, cytotoxicity, anti-inflammatory effects, and potential therapeutic uses of lignans in cancer treatment, neuroprotection, hepatoprotection, and antimicrobial activities.
- Lignans
- Biosynthesis
- Pharmacological Activities
- Anticancer Agents
- Antioxidant
- Medicinal Plants
- Podophyllotoxin
- Schisandra chinensis
- Arctium lappa
- Dirigent Proteins
- Research works
- 5.8k fractional, since 1951
- In the world top 10%
- 576 per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +18% the tick is no change
- Largest producer
China
59% of the 10 largest, 2022-now
Which countries lead Plant-derived Lignans Synthesis and Bioactivity research?
By volume, China and India publish the most (507 and 90 works in 2022-now).
By volume, 2022-now
- 1
China
507 works
- 2
India
90 works
- 3
South Korea
51 works
- 4
Indonesia
48 works
- 5
United States
45 works
- 6
Japan
40 works
- 7
Vietnam
23 works
- 8
Brazil
22 works
- 9
Taiwan
20 works
- 10
Iran
18 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Plant-derived Lignans Synthesis and Bioactivity research?
By volume in 2022-now, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Plant-derived Lignans Synthesis and Bioactivity research, followed by Chinese Academy of Sciences and Heilongjiang University of Chinese Medicine.
By volume, 2022-now
- 1
Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina
19 works
- 2
Chinese Academy of SciencesChina
16 works
- 3
Heilongjiang University of Chinese MedicineChina
9 works
- 4
Shenyang Pharmaceutical UniversityChina
9 works
- 5
Chinese Academy of Agricultural SciencesChina
9 works
- 6
Vietnam Academy of Science and TechnologyVietnam
8 works
- 7
China Pharmaceutical UniversityChina
7 works
- 8
Chengdu University of Traditional Chinese MedicineChina
7 works
- 9
Hunan University of Traditional Chinese MedicineChina
6 works
- 10
First Affiliated Hospital of Henan UniversityChina
6 works
Who are the leading researchers in Plant-derived Lignans Synthesis and Bioactivity?
The most-cited researchers publishing on Plant-derived Lignans Synthesis and Bioactivity include Eric B. Rimm and Frank J. Gonzalez.
- 1
Eric B. Rimm
United States
153k citations
- 2
Frank J. Gonzalez
United States
153k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Plant-derived Lignans Synthesis and Bioactivity research done?
The largest centres of Plant-derived Lignans Synthesis and Bioactivity research in 2022-now are Beijing (China), Guangzhou (China), Shanghai (China) and Nanjing (China).
Where is the best place to study Plant-derived Lignans Synthesis and Bioactivity?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Heilongjiang University of Chinese Medicine and Shenyang Pharmaceutical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina |
56.0 | 8.8% | 18.4× | 19 | +31.7% |
| 2 | Heilongjiang University of Chinese MedicineChina |
51.8 | 22.4% | 108.0× | 9 | +159.0% |
| 3 | Shenyang Pharmaceutical UniversityChina |
4.1 | 4.8% | 71.5× | 9 | -8.9% |
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Plant-derived Lignans Synthesis and Bioactivity, country by countryIs Plant-derived Lignans Synthesis and Bioactivity research growing?
Output in 2022-2025 was 18% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Plant-derived Lignans Synthesis and Bioactivity.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Plant-derived Lignans Synthesis and Bioactivity as a percentage of every work published that year, 0.0040% in 2024.
Fractional works of Plant-derived Lignans Synthesis and Bioactivity over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Plant-derived Lignans Synthesis and Bioactivity. Posts are plain text and can be reported.